Rodger Novak Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rodger Novak.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Rodger Novak for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 10,825 | 19,593 | 68,093 | |
| Jun 23 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.37 | 10,825 | 166,388 | 1,215,005 | 1.2 M to 1.2 M (-0.88 %) |
| Jun 23 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 10,825 | 19,593 | 1,225,830 | 1.2 M to 1.2 M (+0.89 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 11,578 | 20,956 | 78,918 | |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 3,252 | 5,886 | 90,496 | |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 15,392 | 27,860 | 93,748 | |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.02 | 11,578 | 173,846 | 1,215,005 | 1.2 M to 1.2 M (-0.94 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 11,578 | 20,956 | 1,266,583 | 1.3 M to 1.3 M (+0.92 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.00 | 3,252 | 48,785 | 1,215,005 | 1.2 M to 1.2 M (-0.27 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 3,252 | 5,886 | 1,218,257 | 1.2 M to 1.2 M (+0.27 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.00 | 15,392 | 230,880 | 1,215,005 | 1.2 M to 1.2 M (-1.25 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 15,392 | 27,860 | 1,230,397 | 1.2 M to 1.2 M (+1.27 %) |
| Jun 19 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | A | 14.43 | 270,000 | 3,896,100 | 270,000 | |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 1,100 | 1,991 | 109,140 | |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 4,203 | 7,607 | 110,240 | |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.08 | 1,100 | 16,583 | 1,215,005 | 1.2 M to 1.2 M (-0.09 %) |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 1,100 | 1,991 | 1,216,105 | 1.2 M to 1.2 M (+0.09 %) |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.00 | 4,203 | 63,045 | 1,215,005 | 1.2 M to 1.2 M (-0.34 %) |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 4,203 | 7,607 | 1,219,208 | 1.2 M to 1.2 M (+0.35 %) |
| Jun 01 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 3,650 | 6,607 | 114,443 | |
| Jun 01 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.02 | 3,650 | 54,829 | 1,215,005 | 1.2 M to 1.2 M (-0.30 %) |
| Jun 01 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 3,650 | 6,607 | 1,218,655 | 1.2 M to 1.2 M (+0.30 %) |